The pharmacokinetics of midazolam in man

No abstract is available for this paper.

• Publication year

  2004

• Venue

  European Journal of Clinical Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF00562804PMID 6116606
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of two benzodiazepines for anaesthesia induction: midazolam and diazepam

  1978cited by this paper
• Determination of water soluble imidazo-1,4-benzodiazepines in blood by electron- capture gas--liquid chromatography and in urine by differential pulse polaragraphy.

  1978influential reference
• CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates.

  1976cited by this paper
• Chemistry of benzodiazepines

  1968cited by this paper

• Prediction of Pharmacokinetics for CYP3A4-Metabolized Drugs in Pediatrics and Geriatrics Using Dynamic Age-Dependent Physiologically Based Pharmacokinetic Models

  2025influential citation
• Refining High-Throughput In Vitro-In vivo Extrapolation Modeling through Incorporation of Intestinal Toxicokinetics.

  2025cites this paper
• Wastewater Surveillance for Benzodiazepines in Wuhu, China: Occurrence, Removal, and Consumption Patterns

  2025cites this paper
• Anesthetic Management With Remimazolam for Adolescent Mitochondrial Encephalomyopathy With Lactic Acidosis and Stroke-like Episodes (MELAS): A Case Report.

  2025cites this paper
• A primary human Gut/Liver microphysiological system to estimate human oral bioavailability

  2025cites this paper
• A prospective randomized double-blind study of nebulised dexmedetomidine versus midazolam for pediatric premedication

  2025cites this paper
• Towards More Robust Evaluation of the Predictive Performance of Physiologically Based Pharmacokinetic Models: Using Confidence Intervals to Support Use of Model-Informed Dosing in Clinical Care

  2024cites this paper
• Midazolam Boosting With Cobicistat in a Patient With Drug-Resistant Epilepsy and Focal Status Epilepticus

  2024cites this paper
• Identification of Drug Metabolites with Infrared Ion Spectroscopy – Application to Midazolam in vitro Metabolism**

  2023cites this paper
• A Combination of Machine Learning and PBPK Modeling Approach for Pharmacokinetics Prediction of Small Molecules in Humans

  2023cites this paper
• Effect of sedative premedication with oral midazolam on postanesthesia care unit delirium in older adults: a secondary analysis following an uncontrolled before-after design

  2022cites this paper
• Structural Modification in Anesthetic Drug Development for Prodrugs and Soft Drugs

  2022cites this paper
• Anesthetic Drugs: A Comprehensive Overview for Primary Care

  2022cites this paper
• Anesthetic drugs: a comprehensive overview for anesthesiologists

  2021cites this paper
• A Pharmacokinetic-Pharmacodynamic Study of Intravenous Midazolam and Flumazenil in Adult New Zealand White-Californian Rabbits (Oryctolagus cuniculus).

  2021cites this paper
• A Review on the use of Midazolam as a Co-induction Agent

  2021cites this paper
• Pharmacokinetic study of midazolam and α-hydroxymidazolam in guinea pig blood and hair roots after a single dose of midazolam.

  2021cites this paper
• Evaluation of the drug‐drug interaction potential of treosulfan using a physiologically‐based pharmacokinetic modelling approach

  2021cites this paper
• Comparative study of ropivacaine with tramadol and ropivacaine with midazolam for post-operative epidural analgesia

  2021cites this paper
• Conscious IV Sedation Utilizing Midazolam

  2020cites this paper
• The Necessity of Using Changes in Absorption Time to Implicate Intestinal Transporter Involvement in Oral Drug-Drug Interactions

  2020cites this paper
• Propofol alone prevents worsening hepatic encephalopathy rather than midazolam alone or combined sedation after esophagogastroduodenoscopy in compensated or decompensated cirrhotic patients

  2020cites this paper
• Pre-operative Anxiety in Pediatric Surgery Patients: Multiple Case Study Analysis with Literature Review

  2020cites this paper
• Midazolam oral solution (Ozalin®): a profile of its use for procedural sedation or premedication before anaesthesia in children

  2019cites this paper
• Pharmacokinetics and Pharmacology of Drugs Used in Children

  2019cites this paper
• Tacrolimus blood concentration increase depends on administration route when combined with voriconazole in pediatric stem cell transplant recipients

  2019cites this paper
• Midazolam: Safety of use in palliative care: A systematic critical review.

  2019cites this paper
• Use of oral midazolam as a premedication in patients undergoing diagnostic UGI Endoscopy: A double blind placebo controlled randomized trial

  2019cites this paper
• Model qualification of the PK-Sim® pediatric module for pediatric exposure assessment of CYP450 metabolized compounds

  2019cites this paper
• Oral Sedation

  2019cites this paper
• Sorafenib N-Oxide Is an Inhibitor of Human Hepatic CYP3A4

  2019cites this paper
• Medikamente zur intravenösen Narkoseinduktion: Ketamin, Midazolam und Synopsis der gängigen Hypnotika

  2018cites this paper
• The emergence of new psychoactive substance (NPS) benzodiazepines: A review.

  2018cites this paper
• Translational physiologically-based pharmacokinetic (PBPK) modeling and simulation to support drug development and pharmacotherapy

  2018cites this paper
• CYP3A4‐mediated effects of rifampicin on the pharmacokinetics of vilaprisan and its UGT1A1‐mediated effects on bilirubin glucuronidation in humans

  2018cites this paper
• PBPK Models for CYP3A4 and P‐gp DDI Prediction: A Modeling Network of Rifampicin, Itraconazole, Clarithromycin, Midazolam, Alfentanil, and Digoxin

  2018cites this paper
• Midazolam addition to analgosedation for pulmonary vein isolation may increase risk of hypercapnia and acidosis.

  2018cites this paper
• The emergence of new psychoactive substance (NPS) benzodiazepines: A review.

  2018cites this paper
• European Society of Anaesthesiology and European Board of Anaesthesiology guidelines for procedural sedation and analgesia in adults

  2017cites this paper
• Pharmacokinetics and pharmacodynamics of a new highly concentrated intranasal midazolam formulation for conscious sedation

  2017cites this paper
• Pharmacokinetics and pharmacodynamics of midazolam following intravenous and intramuscular administration to sheep.

  2017cites this paper
• A Two-way Randomized Cross-over Pharmacokinetic and Pharmacodynamic Study of an Innovative Oral Solution of Midazolam (ADV6209)

  2017cites this paper
• In vivo Phenotyping Methods: Cytochrome P450 Probes with Emphasis on the Cocktail Approach.

  2017cites this paper
• The impact of obesity on the pharmacokinetics of drugs in adolescents and adults

  2016cites this paper
• Meta‐analysis of hepatic cytochrome P450 ontogeny to underwrite the prediction of pediatric pharmacokinetics using physiologically based pharmacokinetic modeling

  2016cites this paper
• Mechanistic Modeling to Predict Midazolam Metabolite Exposure from In Vitro Data

  2016cites this paper
• Anesthetic Drugs Pharmacokinetics and Pharmacodynamics

  2016cites this paper
• Clarithromycin, Midazolam, and Digoxin: Application of PBPK Modeling to Gain New Insights into Drug–Drug Interactions and Co-medication Regimens

  2016cites this paper
• Propofol versus Midazolam for Upper Gastrointestinal Endoscopy in Cirrhotic Patients: A Meta-Analysis of Randomized Controlled Trials

  2015cites this paper
• Automated Detection of Benzodiazepine Dosage in ICU Patients through a Computational Analysis of Electrocardiographic Data

  2015cites this paper
• Sedative effect of innovative midazolam vs. generic in Wistar rats

  2015cites this paper
• Comparative pharmacokinetics and bioavailability of intranasal and rectal midazolam formulations relative to buccal administration in rabbits

  2015cites this paper
• Benzodiazepines Used in the Treatment of Epilepsy

  2015cites this paper
• CYP3A5*3 and bilirubin predict midazolam population pharmacokinetics in Asian cancer patients

  2014cites this paper
• Automated high-capacity on-line extraction and bioanalysis of dried blood spot samples using liquid chromatography/high-resolution accurate mass spectrometry.

  2014cites this paper
• Surgical Management of Isolated Fractures of Zygoma under Local Anaesthesia and Intra Venous Midazolam.

  2014cites this paper
• A Re-evaluation and Validation of Ontogeny Functions for Cytochrome P450 1A2 and 3A4 Based on In Vivo Data

  2014cites this paper
• Microsoft Word-64447191-file00.docx

  2014cites this paper
• Prediction of human systemic, biologically relevant pharmacokinetic (PK) properties using quantitative structure pharmacokinetic relationships (QSPKR) and interspecies pharmacokinetic allometric scaling (PK-AS) approaches for four different pharmacological classes of compounds

  2014cites this paper
• Deciding on Success Criteria for Predictability of Pharmacokinetic Parameters from In Vitro Studies: An Analysis Based on In Vivo Observations

  2014cites this paper
• Midazolam Pharmacokinetics in Morbidly Obese Patients Following Semi-Simultaneous Oral and Intravenous Administration: A Comparison with Healthy Volunteers

  2014cites this paper
• Issues in the Management of Acute Agitation: How Much Current Guidelines Consider Safety?

  2013cites this paper
• Microsoft Word-42761122-file00.docx

  2013cites this paper
• Utility of In Vitro Systems and Preclinical Data for the Prediction of Human Intestinal First-Pass Metabolism during Drug Discovery and Preclinical Development

  2013cites this paper
• Pharmacokinetics and pharmacodynamics of midazolam after intravenous and intramuscular administration in alpacas.

  2013cites this paper
• Intranasal delivery of rapid acting drugs : studies of pharmacokinetics, effect, tolerability, and satisfaction

  2013cites this paper
• Alternative Delivery Systems for Agents to Treat Acute Agitation: Progress to Date

  2013cites this paper
• Maturation of cytochrome P450 3A mediated drug metabolism: Towards individualized dosing in children

  2013cites this paper
• A Phase I Study Evaluating the Effect of Everolimus on the Pharmacokinetics of Midazolam in Healthy Subjects

  2013influential citation
• Developmental Changes in the Expression and Function of Cytochrome P450 3A Isoforms: Evidence from In Vitro and In Vivo Investigations

  2013cites this paper
• In vitro-in vivo extrapolation of clearance: modeling hepatic metabolic clearance of highly bound drugs and comparative assessment with existing calculation methods.

  2012cites this paper
• Randomized controlled trial for endoscopy with propofol versus midazolam on psychometric tests and critical flicker frequency in people with cirrhosis

  2012cites this paper
• Optimal design methods that are robust to uncertainty

  2012cites this paper
• Sub-clinical hepatic encephalopathy in cirrhotic patients is not aggravated by sedation with propofol compared to midazolam: a randomized controlled study.

  2011cites this paper
• Evaluation of the effects of therapeutic hypothermia and cardiac arrest on specific cytochrome P450 isoform activity

  2011cites this paper
• A Comparison of Dexmedetomidine and Midazolam for Sedation in Gynecologic Surgery Under Epidural Anesthesia

  2011cites this paper
• "In-vivo" phenotyping of CYP3A using midazolam as probe drug : development of novel approaches based on highly sensitive LC-MS/MS methods

  2011cites this paper
• Pharmacology of Pediatric Anesthesia

  2011cites this paper
• Profound changes in drug metabolism enzymes and possible effects on drug therapy in neonates and children

  2011cites this paper
• Effects of oral clotrimazole troches on the pharmacokinetics of oral and intravenous midazolam.

  2010cites this paper
• Current Cytochrome P450 Phenotyping Methods Applied to Metabolic Drug-Drug Interaction Prediction in Dogs

  2010influential citation
• A review of the clinical pharmacokinetics of opioids, benzodiazepines, and antimigraine drugs delivered intranasally.

  2009cites this paper
• Benzodiazepines used Primarily for Emergency Treatment (Diazepam, Lorazepam and Midazolam)

  2009cites this paper
• Pfizer Animal Health, Veterinary Medicine Research & Development, Metabolism & Safety, 333 Portage Street, KZO-300-421NW, Kalamazoo, MI 49001

  2009cites this paper
• Bispectral Index Monitoring of Midazolam Sedation During Flexible Bronchoscopy

  2009cites this paper
• Evaluation of Recombinant Cytochrome P450 Enzymes as an in Vitro System for Metabolic Clearance Predictions

  2009cites this paper
• Pregnancy Does Not Increase CYP3A or P-Glycoprotein Activity in the Non-Human Primate, Macaca nemestrina

  2009cites this paper
• Identification of a Cranberry Juice Product that Inhibits Enteric CYP3A-Mediated First-Pass Metabolism in Humans

  2009cites this paper
• Administration of midazolam in infancy does not affect learning and memory of adult mice

  2009cites this paper
• Pharmacodynamic and pharmacokinetic effects of the intravenously administered CB1 receptor agonist Org 28611 in healthy male volunteers

  2009cites this paper
• Adenosine and adenosine uptake inhibitors potentiate the neuromuscular blocking action of rocuronium mediated by adenosine A1 receptors in isolated rat diaphragms

  2008cites this paper
• Towards Quantitative Prediction of Oral Drug Absorption

  2008cites this paper
• A comparison of dexmedetomidine and midazolam for sedation in third molar surgery *

  2007cites this paper
• Prevention and Intervention Strategies to Alleviate Preoperative Anxiety in Children

  2007influential citation
• Midazolam depresses carotid body chemoreceptor activity

  2006cites this paper
• Marked species differences in the bioavailability of midazolam in cynomolgus monkeys and humans

  2006influential citation
• Midazolam does not inhibit association formation, just its storage and strengthening

  2006cites this paper
• Pharmacokinetics of midazolam, propofol, and fentanyl transfer to human breast milk

  2006cites this paper
• Pharmac . ( 1983 ) , 16 , 43 S-49 S PHARMACOKINETICS AND BIOAVAILABILITY OF MIDAZOLAM IN MAN

  2006cites this paper
• Chapter 6 – Pharmacology of Pediatric Anesthesia

  2006cites this paper